ABBOTT LABORATORIES — Director's Dealing 2006

Feb 22, 2006

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2006-02-17

Reporting Person: LEIDEN JEFFREY M (Director, President and COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2006-02-18	Common shares without par value	F	6102	$44.15	Disposed	303247	Direct
2006-02-17	Common shares without par value	A	100000	$44.16	Acquired	403247	Direct
2006-02-17	Common shares without par value	S	2000	$44.41	Disposed	401247	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2006-02-17	Option (right to buy)	$44.16	A	310000	Acquired	2016-02-16	Common shares (310000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	635	Indirect

Footnotes

F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5 year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of February 16, 2006.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 103,334 on 02/17/2007, 103,333 on 02/17/2008 and 103,333 on 02/17/2009.